BioSpace News Archive

Omnix Medical announced that the Company has received fast-track designation for its novel anti-infective OMN6 from the U.S. Food and Drug Administration.

Diakonos Oncology Corp. announced that Paul Lammers, M.D., M.Sc., a distinguished executive with over 35 years of experience in the biotech and pharmaceutical industries, has been named to its Board of Directors.

MannKind Corporation will release its 2023 fourth quarter and full year financial results and its management will host a conference call to discuss these results and corporate updates at 5:00 PM on Tuesday, February 27, 2024.

Celcuity Inc., a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, announced the appointment of Eldon Mayer as Chief Commercial Officer.

Royal Philips, a global leader in health technology, published its Annual Report 2023.

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that the first subject was dosed in its Phase 1 clinical trial of ARV-102, the Company’s first oral PROTAC® (PROteolysis-TArgeting Chimera) protein degrader in development to treat neurodegenerative diseases.

Kraig Biocraft Laboratories, Inc., announces the creation of its first premium yarn combining its recombinant spider silk with Pima Cotton.